Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionMason & Associates Inc
Latest Disclosed Ownership2,251 shares
Latest Disclosed Value $ 785,763
Mason & Associates Inc ownership in AMGN / Amgen Inc.

On April 30, 2026 - Mason & Associates Inc filed a 13F-HR form disclosing ownership of 2,251 shares of Amgen Inc. (CH:AMGN) valued at $785,763 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 2,251 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F AMGEN COM 031162100 2,251 0 0.00 786 6.66 0.1522
2026-02-05 2025-12-31 13F AMGEN COM 031162100 2,251 266 13.40 737 31.43 0.1387
2025-11-07 2025-09-30 13F AMGEN COM 031162100 1,985 -87 -4.20 560 -3.11 0.1128
2025-07-31 2025-06-30 13F AMGEN COM 031162100 2,072 0 0.00 579 -10.39 0.1336
2025-04-17 2025-03-31 13F AMGEN COM 031162100 2,072 42 2.07 646 21.93 0.1605
2025-01-14 2024-12-31 13F AMGEN COM 031162100 2,030 -243 -10.69 529 -27.73 0.1245
2024-10-23 2024-09-30 13F AMGEN COM 031162100 2,273 210 10.18 733 13.66 0.1827
2024-07-19 2024-06-30 13F AMGEN COM 031162100 2,063 308 17.55 645 29.06 0.1715
2024-04-23 2024-03-31 13F AMGEN COM 031162100 1,755 -280 -13.76 499 -14.85 0.1331
2024-01-17 2023-12-31 13F AMGEN COM 031162100 2,035 -313 -13.33 586 -7.13 0.1723
2023-10-20 2023-09-30 13F AMGEN COM 031162100 2,348 8 0.34 631 21.58 0.2019
2023-07-21 2023-06-30 13F AMGEN COM 031162100 2,340 9 0.39 520 -7.82 0.1533
2023-04-21 2023-03-31 13F AMGEN COM 031162100 2,331 309 15.28 563 6.03 0.1724
2023-01-13 2022-12-31 13F AMGEN COM 031162100 2,022 -26 -1.27 531 14.94 0.1695
2022-10-20 2022-09-30 13F AMGEN COM 031162100 2,048 40 1.99 462 -5.52 0.1636
2022-07-26 2022-06-30 13F AMGEN COM 031162100 2,008 7 0.35 489 1.03 0.1718
2022-04-19 2022-03-31 13F AMGEN COM 031162100 2,001 856 74.76 484 88.33 0.1479
2022-03-18 2021-12-31 13F AMGEN COM 031162100 1,145 1,145 257 0.0781
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.